Information for users of the British Pharmacopoeia during the Transition Period (01 February – 31 December 2020)

Now the UK has left the EU, we would like to reiterate that the UK was a founding member of the Convention on the Elaboration of a European Pharmacopoeia and will continue to be a member of the European Pharmacopoeia (Ph. Eur), as the UK will continue to be a member of the Council of Europe (CoE) in its own right.

The British Pharmacopoeia (BP) continues to reproduce Ph.Eur’s text for the convenience of our customers.

There is now a transition period until the end of 2020 while the UK and EU negotiate additional arrangements.

The current rules on trade and business for the UK and EU will continue to apply during the transition period. This means you can operate as now throughout this period.

New rules will take effect on 1 January 2021.

For any questions please continue to contact our helpdesk at bpcom@mhra.gov.uk.